Oestrogen receptor β and neoadjuvant therapy with tamoxifen: prediction of response and effects of treatment
Open Access
- 18 April 2006
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 94 (9) , 1333-1338
- https://doi.org/10.1038/sj.bjc.6603082
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- A Multi-Centre Investigation Towards Reaching a Consensus on the Immunohistochemical Detection of ERβ in Archival Formalin-fixed Paraffin Embedded Human Breast TissueBreast Cancer Research and Treatment, 2005
- Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47DProceedings of the National Academy of Sciences, 2004
- Evaluation of oestrogen receptor β wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancersEuropean Journal Of Cancer, 2002
- An Estrogen Receptor β Isoform That Lacks Exon 5 Has Dominant Negative Activity on both ERα and ERβBiochemical and Biophysical Research Communications, 2000
- Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonistThe EMBO Journal, 1999
- Cloning and Characterization of Human Estrogen Receptor β IsoformsBiochemical and Biophysical Research Communications, 1998
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- Agonistic Effect of Tamoxifen Is Dependent on Cell Type, ERE-Promoter Context, and Estrogen Receptor Subtype: Functional Difference between Estrogen Receptors α and βBiochemical and Biophysical Research Communications, 1997
- ERβ: Identification and characterization of a novel human estrogen receptorFEBS Letters, 1996
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996